Evidence map›Paper›PMID 41451368›Full record

ReviewFrontiers in pharmacology2025

Biological effects of human placental extracts - variations in manufacturing methods and compositions.

Yikelamu Alimu, Takeshi Yamamoto, Yasukazu Nakahata

Abstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yikelamu AlimuCorporate Planning Department, Melsmon Pharmaceutical Co. Ltd., Tokyo, Japan.
Takeshi YamamotoCorporate Planning Department, Melsmon Pharmaceutical Co. Ltd., Tokyo, Japan.
Yasukazu NakahataDepartment of Integrative Neuroscience, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Placental extracts have been used in traditional medicine across many cultures for centuries. In Traditional Chinese Medicine and Japanese Kampo, placenta has been valued for its ability to reduce fatigue, promote recovery, and enhance vitality. This stems from the belief that the placenta possesses regenerative and life-sustaining properties. In the modern era, the therapeutic use of placenta began with Filatov's "tissue therapy" in the Soviet Union, leading to the development of various extraction techniques from both human and animal placentas. Today, a variety of placental extracts has been manufactured using placentas from humans and livestock. The placental extracts that are currently being manufactured have different compositions owing to differences in origin, placental part used, and manufacturing methods. Despite the differences in the contents of these placental extracts, it has been shown that they exert, to some degree, common biological activities, such as antioxidant, anti-inflammatory, and immunomodulatory functions. Therefore, placental extracts are used as pharmaceuticals to treat menopausal disorders, improve liver function, treat osteoarthritis, and promote wound healing. They are also used as dietary supplements to improve skin texture and for anti-aging purposes. Notably, the relationship between the biological effects of a placental extract and its contents has not been accurately and comprehensively understood. This review summarizes the biological effects and functions of various placental extracts that have been reported to date, including our recent findings, and provides an overview of the biological effects of some human placental extracts for which we were able to obtain the manufacturing method information.

Indexed as

biological effectshuman placental extractsLaennecmanufacturing methodsMelsmonPlacentrex

Identifiers

PMID41451368
PMCPMC12727924

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.